The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation

Gynecological Endocrinology

Volumn 31, Issue 2, 2015, Pages 141-144

  Yazici Yilmaz, Fatma ^a   Görkemli, Hüseyin ^b   Çolakoʇlu, Mehmet Cengiz ^b   Aktan, Murat ^b   Gezginҫ, Kazim ^b  

^a Sisli Etfal Research Hospital   (Turkey)

^b NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

GnRH agonist long protocol; R LH; Suboptimal ovarian response

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; FERTILITY PROMOTING AGENT; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; RECOMBINANT PROTEIN;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; IMPLANTATION; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE INFERTILITY; OVARY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VAGINISM; YOUNG ADULT; AGONISTS; CLINICAL TRIAL; DOWN REGULATION; INFERTILITY, FEMALE; NIDATION; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; TREATMENT FAILURE;

ADULT; DOWN-REGULATION; EMBRYO IMPLANTATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RECOMBINANT PROTEINS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84921366476     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.965675     Document Type: Article

References (19)

1. Alviggi C, Clarizia R, Mollo A, et al. Who needs LH in ovarian stimulation? Reprod Biomed Online 2011;22:33-41.
2. Lévy DP, Navarro JM, Schattman GL, et al. The role of LH in ovarian stimulation: exogenous LH: let's design the future. Hum Reprod 2000;15:2258-65.
3. Fischer R. Understanding the role of LH: myths and facts. Reprod Biomed Online 2007;15:468-77.
4. Sen A, Caiazza F. Oocyte maturation: a story of arrest and release. Front Biosci (Schol Ed) 2013;5:451-77.
5. Shoham Z, Schacter M, Loumaye E, et al. The luteinizing hormone surge-the final stage in ovulation induction: modern aspects of ovulation triggering. Fertil Steril 1995;64:237-51.
6. Lehert P, Kolibianakis EM, Venetis CA, et al. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol 2014;20:12-17.
7. Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507-14.
8. Fleming R, Lloyd F, Herbert M, et al. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788-92.
9. Lisi F, Rinaldi L, Fishel S, et al. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril 2005;83:309-15.
10. Fanchin R, Schonauer LM, Mahjoub S, et al. Residual LH concentration after GnRH agonist administration influence ovarian response to recombinant FSH, embryo quality, and IVF-embryo transfer outcome. Hum Reprod 2001;16:14-15.
11. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000;15:1003-8.
12. Matorras R, Prieto B, Exposito A, et al. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study. Reprod Biomed Online 2009;19:879-87.
13. De Placido G, Alviggi C, Perino A, et al.; Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-6.
14. Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17:2016-21.
15. Franco Jr JG, Baruffi RL, Oliveira JB, et al. Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: a matched case-control study. Reprod Biol Endocrinol 2009;7:58.
16. Marrs R, Meldrum D, Muasher S, et al. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 2004;8:175-82.
17. De Placido G, Alviggi C, Mollo A, et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxf) 2004;60:637-43.
18. Gómez-Palomares JL, Acevedo-Martín B, Andrés L, et al. LH improves early follicular recruitment in women over 38 years old. Reprod Biomed Online 2005;11:409-14.
19. Sönmezer M, Iltemir Duvan C, Ozmen B, et al. Outcomes after early or midfollicular phase LH supplementation in previous inadequate responders. Reprod Biomed Online 2010;20:350-7.